Schroder Investment Management Group
AMAG

Schroder Investment Management Group’s AMAG Pharmaceuticals AMAG Stock Holding History

Schroder Investment Management Group’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-47,116
Closed -$607K – 1265
2019
Q1 		$607K Buy
+47,116
New +$702K ﹤0.01% 980
2017
Q4 		– Sell
-83,945
Closed -$1.49M – 1400
2017
Q3 		$1.49M Buy
83,945
+42,233
+101% +$787K ﹤0.01% 921
2017
Q2 		$761K Buy
41,712
+4,264
+11% +$84.5K ﹤0.01% 1015
2017
Q1 		$859K Buy
+37,448
New +$897K ﹤0.01% 973

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group's AMAG Position: Q2 2019 in Review

Schroder Investment Management Group sold out of AMAG Pharmaceuticals (AMAG) in Q2 2019, closing a stake of 47,116 shares — an estimated $607K sold.

Schroder Investment Management Group first reported a position in AMAG in Q1 2017 and held it in 4 quarters. The position peaked at $1.49M in Q3 2017. 170 funds tracked by Wall St. Rank hold AMAG as of Q2 2019.

  • Schroder Investment Management Group reported no remaining AMAG Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Schroder Investment Management Group sold 47,116 AMAG Pharmaceuticals shares in Q2 2019, an estimated $607K.
  • Schroder Investment Management Group first reported a position in AMAG Pharmaceuticals in Q1 2017 and held it in 4 quarters.
  • Schroder Investment Management Group's AMAG Pharmaceuticals position peaked at $1.49M in Q3 2017.
  • 170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2019.

Based on Schroder Investment Management Group's 13F filing for Q2 2019, filed 8 Aug 2019.